Agenus Inc AGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
1.60quote price arrow up+0.03 (+1.91%)
Volume
22,532
Close
1.57quote price arrow up+0.03 (+1.95%)
Volume
2,372,500
52 week range
1.46 - 6.79
Loading...
  • Open1.57
  • Day High1.61
  • Day Low1.49
  • Prev Close1.54
  • 52 Week High6.79
  • 52 Week High Date08/30/21
  • 52 Week Low1.46
  • 52 Week Low Date05/19/22

Key Stats

  • Market Cap424.32M
  • Shares Out270.27M
  • 10 Day Average Volume5.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-51.24

KEY STATS

  • Open1.57
  • Day High1.61
  • Day Low1.49
  • Prev Close1.54
  • 52 Week High6.79
  • 52 Week High Date08/30/21
  • 52 Week Low1.46
  • 52 Week Low Date05/19/22
  • Market Cap424.32M
  • Shares Out270.27M
  • 10 Day Average Volume5.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-51.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-16.37
  • Fwd P/E (NTM)-1.58
  • EBITDA (TTM)50.365M
  • ROE (TTM)-421.78%
  • Revenue (TTM)309.89M
  • Gross Margin (TTM)99.06%
  • Net Margin (TTM)-8.04%
  • Debt To Equity (MRQ)90.22%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agenus Inc

There is no recent news for this security.

Profile

MORE
Agenus Inc. is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, vaccines and adjuvants. Its antibody candidates are Balstilimab (an anti-PD-1 antibody) and Zalifrelimab (an anti-CTLA-4 antibody), which is in Phase 2 trials as both a monotherapy...
Garo Armen Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Christine Klaskin
Vice President - Finance
Address
3 Forbes Rd
Lexington, MA
02421-7305
United States

Top Peers

SYMBOLLASTCHG%CHG
MDXG
MiMedx Group Inc
3.60-0.01-0.28%
CHRS
Coherus BioSciences Inc
8.31+0.40+5.06%
KPTI
Karyopharm Therapeutics Inc
5.82+0.17+3.01%
AVIR
Atea Pharmaceuticals Inc
7.49+0.24+3.31%
ICPT
Intercept Pharmaceuticals Inc
17.46+0.30+1.75%